MicroRNA-145 inhibits migration and invasion by down-regulating FSCN1 in lung cancer

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 6, 2015, Pages 8794-8802

  Zhang, Ye ^a   Lin, Qing ^a  

^a Jiangxi Provincial People's Hospital   (China)

Author keywords

FSCN1; Lung cancer; MiR 145

Indexed keywords

ACTIN BINDING PROTEIN; FASCIN HOMOLOG 1; FIBRONECTIN; LUCIFERASE; MICRORNA 145; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BIOINFORMATICS; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FILTERS AND MEMBRANES; GEL ELECTROPHORESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG CANCER; MTT ASSAY; NON SMALL CELL LUNG CANCER; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84938295343     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. [1] Blanco R, Maestu I, de la Torre MG, Cassinello A and Nunez I. A review of the management of elderly patients with non-small-cell lung cancer. Ann Oncol 2015; 26: 451-463.
2. [2] Shukla GC, Singh J and Barik S. MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Mol Cell Pharmacol 2011; 3: 83-92.
3. [3] Flynt AS and Lai EC. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet 2008; 9: 831-842.
4. [4] Friedman RC, Farh KK, Burge CB and Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
5. [5] Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev 2006; 16: 4-9.
6. [6] Ozen M, Creighton CJ, Ozdemir M and Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008; 27: 1788-1793.
7. [7] Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M and Seki N. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 2009; 125: 345-352.
8. [8] Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K and Mo YY. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A 2009; 106: 3207-3212.
9. [9] Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW and Kim S. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 2008; 14: 2690-2695.
10. [10] Yuan W, Sun W, Yang S, Du J, Zhai CL, Wang ZQ, Zhang J and Zhu TH. Downregulation of microRNA-142 by proto-oncogene LMO2 and its co-factors. Leukemia 2008; 22: 1067-1071.
11. [11] La Rocca G, Badin M, Shi B, Xu SQ, Deangelis T, Sepp-Lorenzinoi L and Baserga R. Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway. J Cell Physiol 2009; 220: 485-491.
12. [12] Jia Y, Liu H, Zhuang Q, Xu S, Yang Z, Li J, Lou J and Zhang W. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. Oncol Rep 2012; 27: 1865-1872.
13. [13] Lu Y, Chopp M, Zheng X, Katakowski M, Buller B and Jiang F. MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. Oncol Rep 2013; 29: 67-72.
14. [14] Sachdeva M and Mo YY. miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res 2010; 2: 170-180.
15. [15] Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and Matsubara H. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 2010; 127: 2804-2814.
16. [16] Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
17. [17] Wakelee HA, Bernardo P, Johnson DH and Schiller JH. Changes in the natural history ofnonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990. Cancer 2006; 106: 2208-2217.
18. [18] Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004; 16: 590-596.
19. [19] Peraud A, Mondal S, Hawkins C, Mastronardi M, Bailey K and Rutka JT. Expression of fascin, an actin-bundling protein, in astrocytomas of varying grades. Brain Tumor Pathol 2003; 20: 53-58.